Immunological Monitoring of CML Patients during First-Line Bosutinib and Imatinib Treatment

Anna Kreutzman, Perttu Koskenvesa, Kasanen Tiina, Ulla Olsson-Stromberg, Jesper Stentoft, Leif Stenke, Lene Udby, Bjorn T. Gjertsen, Kourosh Lotfi, Berit Markevan, Jeroen Janssen, Tim Brummendorf, Johan Richter, Henrik Hjorth-Hansen, Satu Mustjoki

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Original languageEnglish
JournalBlood
Volume128
Issue number22
Number of pages5
ISSN0006-4971
Publication statusPublished - 2 Dec 2016
Event58th Annual Meeting and Exposition of the American-Society-of-Hematology - San Diego, Canada
Duration: 3 Dec 20166 Dec 2016

Cite this

Kreutzman, Anna ; Koskenvesa, Perttu ; Tiina, Kasanen ; Olsson-Stromberg, Ulla ; Stentoft, Jesper ; Stenke, Leif ; Udby, Lene ; Gjertsen, Bjorn T. ; Lotfi, Kourosh ; Markevan, Berit ; Janssen, Jeroen ; Brummendorf, Tim ; Richter, Johan ; Hjorth-Hansen, Henrik ; Mustjoki, Satu. / Immunological Monitoring of CML Patients during First-Line Bosutinib and Imatinib Treatment. In: Blood. 2016 ; Vol. 128, No. 22.
@article{29c098640c7444aca298b00cdbea8452,
title = "Immunological Monitoring of CML Patients during First-Line Bosutinib and Imatinib Treatment",
author = "Anna Kreutzman and Perttu Koskenvesa and Kasanen Tiina and Ulla Olsson-Stromberg and Jesper Stentoft and Leif Stenke and Lene Udby and Gjertsen, {Bjorn T.} and Kourosh Lotfi and Berit Markevan and Jeroen Janssen and Tim Brummendorf and Johan Richter and Henrik Hjorth-Hansen and Satu Mustjoki",
year = "2016",
month = "12",
day = "2",
language = "English",
volume = "128",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "22",

}

Kreutzman, A, Koskenvesa, P, Tiina, K, Olsson-Stromberg, U, Stentoft, J, Stenke, L, Udby, L, Gjertsen, BT, Lotfi, K, Markevan, B, Janssen, J, Brummendorf, T, Richter, J, Hjorth-Hansen, H & Mustjoki, S 2016, 'Immunological Monitoring of CML Patients during First-Line Bosutinib and Imatinib Treatment', Blood, vol. 128, no. 22.

Immunological Monitoring of CML Patients during First-Line Bosutinib and Imatinib Treatment. / Kreutzman, Anna; Koskenvesa, Perttu; Tiina, Kasanen; Olsson-Stromberg, Ulla; Stentoft, Jesper; Stenke, Leif; Udby, Lene; Gjertsen, Bjorn T.; Lotfi, Kourosh; Markevan, Berit; Janssen, Jeroen; Brummendorf, Tim; Richter, Johan; Hjorth-Hansen, Henrik; Mustjoki, Satu.

In: Blood, Vol. 128, No. 22, 02.12.2016.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

TY - JOUR

T1 - Immunological Monitoring of CML Patients during First-Line Bosutinib and Imatinib Treatment

AU - Kreutzman, Anna

AU - Koskenvesa, Perttu

AU - Tiina, Kasanen

AU - Olsson-Stromberg, Ulla

AU - Stentoft, Jesper

AU - Stenke, Leif

AU - Udby, Lene

AU - Gjertsen, Bjorn T.

AU - Lotfi, Kourosh

AU - Markevan, Berit

AU - Janssen, Jeroen

AU - Brummendorf, Tim

AU - Richter, Johan

AU - Hjorth-Hansen, Henrik

AU - Mustjoki, Satu

PY - 2016/12/2

Y1 - 2016/12/2

M3 - Meeting Abstract

VL - 128

JO - Blood

JF - Blood

SN - 0006-4971

IS - 22

ER -

Kreutzman A, Koskenvesa P, Tiina K, Olsson-Stromberg U, Stentoft J, Stenke L et al. Immunological Monitoring of CML Patients during First-Line Bosutinib and Imatinib Treatment. Blood. 2016 Dec 2;128(22).